Dysregulation of energy metabolism in Alzheimer's disease

被引:0
|
作者
Yue Yuan [1 ]
Gang Zhao [2 ]
Yang Zhao [1 ]
机构
[1] The First Hospital of Jilin University,Department of Neurology
[2] China Resources Pharmaceutical Commercial Group,undefined
关键词
Alzheimer’s disease; Glucose metabolism; Glucose transporters; O-GlcNAc; Mitochondrial dysfunction; Mitochondrial autophagy; Mitochondrial genetics; β-Amyloid; Tau protein;
D O I
10.1007/s00415-024-12800-8
中图分类号
学科分类号
摘要
Alzheimer's disease (AD) is one of the most common neurodegenerative diseases. Its etiology and associated mechanisms are still unclear, which largely hinders the development of AD treatment strategies. Many studies have shown that dysregulation of energy metabolism in the brain of AD is closely related to disease development. Dysregulation of brain energy metabolism in AD brain is associated with reduced glucose uptake and utilization, altered insulin signaling pathways, and mitochondrial dysfunction. In this study, we summarized the relevant pathways and mechanisms regarding the dysregulation of energy metabolism in AD. In addition, we highlight the possible role of mitochondrial dysfunction as a central role in the AD process. A deeper understanding of the relationship between energy metabolism dysregulation and AD may provide new insights for understanding learning memory impairment in AD patients and in improving AD prevention and treatment.
引用
收藏
相关论文
共 50 条
  • [31] Brain energy metabolism and genetic predisposition to Alzheimer's disease.
    Fokin, V
    Pnomareva, N
    Selesneva, N
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2000, 96 (04): : 521 - 521
  • [32] Metabolic Dysregulation Contributes to the Progression of Alzheimer's Disease
    Yan, Xu
    Hu, Yue
    Wang, Biyao
    Wang, Sijian
    Zhang, Xinwen
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [33] Polyamine Dysregulation and Nucleolar Disruption in Alzheimer's Disease
    Brooks, Wesley Harrell
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 98 (03) : 837 - 857
  • [34] Evidence for brain glucose dysregulation in Alzheimer's disease
    An, Yang
    Varma, Vijay R.
    Varma, Sudhir
    Casanova, Ramon
    Dammer, Eric
    Pletnikova, Olga
    Chia, Chee W.
    Egan, Josephine M.
    Ferrucci, Luigi
    Troncoso, Juan
    Levey, Allan I.
    Lah, James
    Seyfried, Nicholas T.
    Legido-Quigley, Cristina
    O'Brien, Richard
    Thambisetty, Madhav
    ALZHEIMERS & DEMENTIA, 2018, 14 (03) : 318 - 329
  • [35] Dysregulation of Intracellular Calcium Signaling in Alzheimer's Disease
    Popugaeva, Elena
    Pchitskaya, Ekaterina
    Bezprozvanny, Ilya
    ANTIOXIDANTS & REDOX SIGNALING, 2018, 29 (12) : 1176 - 1188
  • [36] The Role of Insulin Dysregulation in Aging and Alzheimer's Disease
    Craft, Suzanne
    DIABETES, INSULIN AND ALZHEIMER'S DISEASE, 2010, : 109 - 127
  • [37] Emerging insights into synapse dysregulation in Alzheimer's disease
    Martinez-Serra, Raquel
    Alonso-Nanclares, Lidia
    Cho, Kwangwook
    Giese, K. Peter
    BRAIN COMMUNICATIONS, 2022, 4 (02)
  • [38] Dysregulation and Diagnostic Potential of microRNA in Alzheimer's Disease
    Pan, Yaoqian
    Liu, Ruizhu
    Terpstra, Erin
    Wang, Yanqing
    Qiao, Fangfang
    Wang, Jin
    Tong, Yigang
    Pan, Bo
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 49 (01) : 1 - 12
  • [39] Complement dysregulation and Alzheimer's disease in Down syndrome
    Veteleanu, Aurora
    Pape, Sarah
    Davies, Kate
    Kodosaki, Eleftheria
    Hye, Abdul
    Zelek, Wioleta M.
    Strydom, Andre
    Morgan, B. Paul
    ALZHEIMERS & DEMENTIA, 2023, 19 (04) : 1383 - 1392
  • [40] Iron Dysregulation in Mitochondrial Dysfunction and Alzheimer's Disease
    Onukwufor, John O.
    Dirksen, Robert T.
    Wojtovich, Andrew P.
    ANTIOXIDANTS, 2022, 11 (04)